Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Ischemic Heart Disease

  Free Subscription


Articles published in Ann Intern Med

Retrieve available abstracts of 21 articles:
HTML format



Single Articles


    November 2021
  1. CHIANG CH, Chiang CH, Pickering JW, Stoyanov KM, et al
    Performance of the European Society of Cardiology 0/1-Hour, 0/2-Hour, and 0/3-Hour Algorithms for Rapid Triage of Acute Myocardial Infarction : An International Collaborative Meta-analysis.
    Ann Intern Med. 2021 Nov 23. doi: 10.7326/M21-1499.
    PubMed     Abstract available


    October 2021
  2. BURNS RB, Pignone M, Michos ED, Kanjee Z, et al
    Would You Recommend Aspirin to This Patient for Primary Prevention of Atherosclerotic Cardiovascular Disease? : Grand Rounds Discussion From Beth Israel Deaconess Medical Center.
    Ann Intern Med. 2021 Oct 12. doi: 10.7326/M21-2596.
    PubMed     Abstract available


    September 2021
  3. PATORNO E, Htoo PT, Glynn RJ, Schneeweiss S, et al
    Sodium-Glucose Cotransporter-2 Inhibitors Versus Glucagon-like Peptide-1 Receptor Agonists and the Risk for Cardiovascular Outcomes in Routine Care Patients With Diabetes Across Categories of Cardiovascular Disease.
    Ann Intern Med. 2021 Sep 28. doi: 10.7326/M21-0893.
    PubMed     Abstract available


    July 2021
  4. JIANG D, Garcia D
    In patients with AMI and anemia, a restrictive vs. liberal blood transfusion strategy was noninferior for 30-d MACE.
    Ann Intern Med. 2021 Jul 6. doi: 10.7326/ACPJ202107200.
    PubMed     Abstract available


    June 2021
  5. TANNER M
    In type 2 diabetes, SGLT2 inhibitors reduce all-cause, but not cardiovascular, mortality vs. GLP-1 RAs.
    Ann Intern Med. 2021 Jun 1. doi: 10.7326/ACPJ202106150.
    PubMed     Abstract available


    April 2021
  6. NEWTON SL, Yeh JS
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:582-583.
    PubMed    


  7. CHOW EJ, O'Halloran A, Rolfes MA, Reed C, et al
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583-584.
    PubMed    


  8. SCHATTNER A
    Acute Cardiovascular Events Associated With Influenza in Hospitalized Adults.
    Ann Intern Med. 2021;174:583.
    PubMed    


    March 2021
  9. NANNA MG, Newby LK
    In coronary artery disease, PCI increases all-cause and cause-specific mortality compared with CABG.
    Ann Intern Med. 2021 Mar 2. doi: 10.7326/ACPJ202103160.
    PubMed     Abstract available


  10. BATES ER
    In patients with CAD, adding colchicine to evidence-based therapies reduces MACE without increasing adverse outcomes.
    Ann Intern Med. 2021;174:JC30.
    PubMed     Abstract available


  11. GIANNASI G, Nanni V, Nucci A, Perini AP, et al
    Acute ST-Segment Elevation From an Ingested Battery: A Case Report.
    Ann Intern Med. 2021;174:425-426.
    PubMed    


    January 2021
  12. COHN JN
    Low-dose colchicine reduced risk for cardiovascular events in chronic coronary disease.
    Ann Intern Med. 2021 Jan 5. doi: 10.7326/ACPJ202101190.
    PubMed     Abstract available


    December 2020
  13. HICKS CW, Wang D, Matsushita K, Windham BG, et al
    Peripheral Neuropathy and All-Cause and Cardiovascular Mortality in U.S. Adults : A Prospective Cohort Study.
    Ann Intern Med. 2020 Dec 8. doi: 10.7326/M20-1340.
    PubMed     Abstract available


    October 2020
  14. BAVISHI C
    In ACS treated with drug-eluting stents and 3 mo of DAPT, ticagrelor monotherapy reduced clinical events at 1 y vs. DAPT.
    Ann Intern Med. 2020;173:JC43.
    PubMed     Abstract available


  15. NANNA MG, Granger CB
    In ACS, ticagrelor and prasugrel each reduce some ischemic events but increase major bleeding vs. clopidogrel.
    Ann Intern Med. 2020;173:JC44.
    PubMed     Abstract available


    September 2020
  16. RESTON JT, Buelt A, Donahue MP, Neubauer B, et al
    Interventions to Improve Statin Tolerance and Adherence in Patients at Risk for Cardiovascular Disease : A Systematic Review for the 2020 U.S. Department of Veterans Affairs and U.S. Department of Defense Guidelines for Management of Dyslipidemia.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4680.
    PubMed     Abstract available


  17. O'MALLEY PG, Arnold MJ, Kelley C, Spacek L, et al
    Management of Dyslipidemia for Cardiovascular Disease Risk Reduction: Synopsis of the 2020 Updated U.S. Department of Veterans Affairs and U.S. Department of Defense Clinical Practice Guideline.
    Ann Intern Med. 2020 Sep 22. doi: 10.7326/M20-4648.
    PubMed     Abstract available


  18. KELSEY MD, Newby LK
    In older patients with NSTE-ACS, clopidogrel safely reduced bleeding compared with ticagrelor at 1 year.
    Ann Intern Med. 2020;173:JC28.
    PubMed     Abstract available


  19. HOFFER EP
    In AF with recent ACS or PCI, apixaban improved 30-day outcomes vs. VKAs; aspirin effects varied vs. placebo.
    Ann Intern Med. 2020;173:JC29.
    PubMed     Abstract available


  20. ELGENDY IY
    In ACS, prasugrel reduces 30-day MACE and mortality vs. ticagrelor or clopidogrel; no differences for major bleeding.
    Ann Intern Med. 2020;173:JC27.
    PubMed     Abstract available


    June 2020
  21. MURRAY H, Slaunwhite E
    Accelerated diagnostic algorithms with hs-cTn have >/= 92% sensitivity but lower specificity for diagnosing AMI.
    Ann Intern Med. 2020;172:JC71.
    PubMed     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Ischemic Heart Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: